Skip to main content

DELINEANDO EL PERFIL MUTACIONAL DEL SARS COV2 EN LA ISLA DE SICILIA: ASPECTOS FUNCIONALES

PID2020-120322RB-C21

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Finding of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) in a Wild Eurasian River Otter ( Lutra lutra) Highlights the Need for Viral Surveillance in Wild Mustelids

  • Padilla-Blanco, Miguel
  • Aguiló-Gisbert, Jordi
  • Rubio, Vicente
  • Lizana, Víctor
  • Chillida-Martínez, Eva
  • Cardells, Jesús
  • Maiques, Elisa
  • Rubio-Guerri, Consuelo
8 páginas, 2 figuras, 2 tablas, Animals have been involved in the three known outbreaks of severe respiratory syndromes due to coronaviruses (years 2005, 2012, and 2019). The pandemic nature of the SARS-CoV-2 outbreak increases the likelihood of infection from humans of susceptible animal species that, thus, could become secondary viral hosts and even disease reservoirs. We present evidence of spillover infection of wild mustelids by reporting the presence of SARS-CoV-2 in a Eurasian river otter found near a water reservoir in the Valencian Community (Spain). We detected the virus using two different commercial RTqPCR assays on RNA extracted from the nasopharynx (swabbing) and from lung tissue and mediastinal lymph node homogenates. The corresponding samples from two additional otters from distant sites tested negative in identical assays. The diagnosis in the positive otter was confirmed by two-tube RT-PCR assay in which RNA was first retrotranscribed, and then specific regions of the spike (S), nucleocapsid (N), and ORF10 genes were separately amplified from the produced cDNA, followed by electrophoretic visualization and Sanger sequencing. The sequences of the amplified products revealed some non-synonymous changes in the N and ORF10 partial sequences, relative to the consensus sequence. These changes, identified already in human patient samples, point to human origin of the virus, although their specific combination was unique. These findings, together with our previous report of SARS-CoV-2 infection of feral American mink, highlight the need for SARS-CoV-2 surveillance of wild or feral mustelids to evaluate the risk that these animals could become SARS-CoV-2 reservoirs., This research received external funding to CR-G and EM from Agencia Valenciana de Innovación: COVID-19. Ayudas de concesión directa a soluciones científico-innovadoras directamente relacionadas con la lucha contra la COVID-19, (Ref COVID-19-203) and from the Conselleria de Innovación Universidades, Ciencia y Sociedad Digital: Subvenciones a grupos de investigación emergentes (Ref, GV/2021/163), and from a grant to VR (PID2020-120322RB-C21) from the Spanish Agencia Estatal de Investigación (Plan Estatal de I+D+i)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pilot Investigation of SARS-CoV-2 Variants in the Island of Sicily Prior to and in the Second Wave of the COVID-19 Pandemic

  • Padilla-Blanco, Miguel
  • Gucciardi, Francesca
  • Guercio, Annalisa
  • Rubio, Vicente
  • Princiotta, Antonina
  • Veses, Veronica
  • Terrana, Mariangela
  • Sheth, Chirag C.
  • Pascual-Ortiz, Marina
  • Maiques, Elisa
  • Purpari, Giuseppa
  • Rubio-Guerri, Consuelo
8 páginas, 2 tablas, 2 figuras. The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/genbank/, OM510944; https://www.ncbi.nlm.nih.gov/genbank/, OM510945; https://www.ncbi. nlm.nih.gov/genbank/, OM510946; https://www.ncbi.nlm.nih. gov/genbank/, OM510947; https://www.ncbi.nlm.nih.gov/genbank/, OM510948; https://www.ncbi.nlm.nih.gov/genbank/, OM510949; https://www.ncbi.nlm.nih.gov/genbank/, OM51 0950; https://www.ncbi.nlm.nih.gov/genbank/, OM510951; and https://www.ncbi.nlm.nih.gov/genbank/, OM510952., After 2 years of the COVID-19 pandemic, we continue to face vital challenges stemming from SARS-CoV-2 variation, causing changes in disease transmission and severity, viral adaptation to animal hosts, and antibody/vaccine evasion. Since the monitoring, characterization, and cataloging of viral variants are important and the existing information on this was scant for Sicily, this pilot study explored viral variants circulation on this island before and in the growth phase of the second wave of COVID-19 (September and October 2020), and in the downslope of that wave (early December 2020) through sequence analysis of 54 SARS-CoV-2-positive samples. The samples were nasopharyngeal swabs collected from Sicilian residents by a state-run one-health surveillance laboratory in Palermo. Variant characterization was based on RT-PCR amplification and sequencing of four regions of the viral genome. The B.1.177 variant was the most prevalent one, strongly predominating before the second wave and also as the wave downsized, although its relative prevalence decreased as other viral variants, particularly B.1.160, contributed to virus circulation. The occurrence of the B.1.160 variant may have been driven by the spread of that variant in continental Europe and by the relaxation of travel restrictions in the summer of 2020. No novel variants were identified. As sequencing of the entire viral genome in Sicily for the period covered here was restricted to seven deposited viral genome sequences, our results shed some light on SARS-CoV-2 variant circulation during that wave in this insular region of Italy which combines its partial insular isolation with being a major entry point for the African immigration., This research received external funding to CR-G and EM from “Agencia Valenciana de Innovación: COVID-19, Ayudas de Concesión Directa a Soluciones Científico-Innovadoras Directamente Relacionadas Con La Lucha Contra La COVID-19,” (Ref COVID-19-203) and from “Conselleria de Innovación Universidades, Ciencia y Sociedad Digital: Subvenciones a Grupos de Investigación Emergentes” (Ref, GV/2021/163); to VR from the Agencia Estatal de Investigación of the Spanish Government (Ref PID2020-120322RB-C21) and from the European Commission–NextGeneration EU CSIC Global Health Platform, Spanish Ministry of Science and Innovation (Ref MCIN/AEI/10.13039/501100011033); and to the Istituto Zooprofilattico Sperimentale della Sicilia “A. Mirri” by the Project “COVID-19: Traiettorie Evolutive di SARS-CoV-2 ed Indagine Sul Ruolo Degli Animali” (IZS SI 03/20 RC), funded by the Italian Ministry of Health., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco-Marín, Clara
  • Wieczor, Milosz
  • Mata, Carlos P.
  • Krieger, James
  • Ruiz-Rodríguez, Paula
  • López-Redondo, Marisa
  • Francés-Gómez, Clara
  • Melero, Roberto
  • Sorzano, Carlos Óscar S.
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada-Nadal, Alicia
  • Zamora-Caballero, Sara
  • Gozalbo-Rovira, Roberto
  • Sanz-Frasquet, Carla
  • Arranz, Rocío
  • Bravo, Jerónimo
  • Rubio, Vicente
  • Marina, Alberto
  • The IBV-Covid19-Pipeline Consortium
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscollá, Mireia
  • Orozco, Modesto
  • Llácer, José Luis
  • Carazo, José M.
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has since reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness., In this research work, PRR and TG were supported by salaries from the European Commission–NextGenerationEU through the CSIC Global Health Platform established by EU Council Regulation 2020/2094. The authors would like to acknowledge economic support from: (a) the Spanish Ministry of Science and Innovation through grants: SEV-2017-0712 funded by MCIN/AEI/10.13039/501100011033 (CPM, JK, RM, COSS, MM, RA, JMC); 116880GB-I00 (JLL) and 120322RB-C21 (VR) funded within PID 2020; PID2019-104757RB-I00 funded by MCIN/AEI/10.13039/501100011033/ and “ERDF A way of making Europe”, by the “European Union” (JMC, COSS, RM, MM, CPM) and 104477RB-100 (IC) funded within PID 2019; RYC-2015-18213 (salary of MC) and RYC-2015-17517 (salary of RG) funded by the Ramon y Cajal fellowship program; RTI2018-094399-A-I00 (JMC, COSS, RM, CPM, MC) funded within the Retos Investigación program; the CRIOMECORR project funded as ESFRI-2019-01-CSIC-16; (b) the Horizon 2020 program through Marie Skłodowska-Curie Individual Fellowships EnLaCES (Proposal 101024130, salary of JK) and EPIDNA (Grant ID: 894498, salary of MW); (c) the European Research Council (ERC) through grants: ERC-2018-SyG-810057 HighResCells funded within the EXCELLENT SCIENCE program (JMC, MM, COSS, salary of RM), Grant 871037 iNEXT DISCOVERY (JMC, MM, COSS) and grant CoG-101001038 funded within the Consolidator Grants program (IC); (d) Generalitat Valenciana through grants: SEJI/2019/011 (MC) and SEJI/2019/030 (JLL); (e) Comunidad de Madrid through grant: S2017/BMD-3817 (JMC); (f) Santander Bank through grant: CSIC-COVID19-082 (AM, VR, JB, JLL, RG) funded through the Fondo Supera Covid-19; (g) Instituto de Salud Carlos III through grants: COV20/00437 (AM, VR, JB, JLL) and COV20/00140 (IC), both funded through the Fondos Covid-19 initiative; (h) Spanish National Research Council through grant: 202080E110 funded within the PTI Salud Global initiative (AM, VR, JB, JLL, RG)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A SARS-CoV-2 full genome sequence of the B.1.1 lineage sheds light on viral evolution in Sicily in late 2020

  • Padilla-Blanco, Miguel
  • Gucciardi, Francesca
  • Rubio, Vicente
  • Lastra, Antonio
  • Lorenzo, Teresa
  • Ballester, Beatriz
  • González-Pastor, Andrea
  • Veses, Verónica
  • Macaluso, Giusi
  • Sheth, Chirag C.
  • Pascual-Ortiz, Marina
  • Maiques, Elisa
  • Rubio-Guerri, Consuelo
  • Purpari, Giuseppa
  • Guercio, Annalisa
9 páginas, 2 figuras, 2 tablas, To investigate the influence of geographic constrains to mobility on SARS-CoV-2 circulation before the advent of vaccination, we recently characterized the occurrence in Sicily of viral lineages in the second pandemic wave (September to December 2020). Our data revealed wide prevalence of the then widespread through Europe B.1.177 variant, although some viral samples could not be classified with the limited Sanger sequencing tools used. A particularly interesting sample could not be fitted to a major variant then circulating in Europe and has been subjected here to full genome sequencing in an attempt to clarify its origin, lineage and relations with the seven full genome sequences deposited for that period in Sicily, hoping to provide clues on viral evolution. The obtained genome is unique (not present in databases). It hosts 20 single-base substitutions relative to the original Wuhan-Hu-1 sequence, 8 of them synonymous and the other 12 encoding 11 amino acid substitutions, all of them already reported one by one. They include four highly prevalent substitutions, NSP12:P323L, S:D614G, and N:R203K/G204R; the much less prevalent S:G181V, ORF3a:G49V and N:R209I changes; and the very rare mutations NSP3:L761I, NSP6:S106F, NSP8:S41F and NSP14:Y447H. GISAID labeled this genome as B.1.1 lineage, a lineage that appeared early on in the pandemic. Phylogenetic analysis also confirmed this lineage diagnosis. Comparison with the seven genome sequences deposited in late 2020 from Sicily revealed branching leading to B.1.177 in one branch and to Alpha in the other branch, and suggested a local origin for the S:G118V mutation., This research received external funding to CR-G from Conselleria de Innovación Universidades, Ciencia y Sociedad Digital: Subvenciones a Grupos de Investigación Emergentes (Ref, GV/2021/163); to VR from the Agencia Estatal de Investigación of the Spanish Government (Ref PID2020-120322RB-C21) and the European Commission-NextGeneration EU CSIC Global Health Platform, Spanish Ministry of Science and Innovation (Ref MCIN/AEI/10.13039/501100011033); and to the Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri by the Project COVID-19: Traiettorie Evolutive di SARS-CoV-2 ed Indagine Sul Ruolo Degli Animali (IZS SI 03/20 RC), funded by the Italian Ministry of Health, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein

  • Gargantilla, Marta
  • Francés-Gómez, Clara
  • Adhav, Anmol
  • Forcada-Nadal, Alicia
  • Martínez-Gualda, Belén
  • Martí-Marí, Olaia
  • López-Redondo, Marisa
  • Melero, Roberto
  • Marco-Marín, Clara
  • Gougeard, Nadine
  • Espinosa, Carolina
  • Rubio-Del-Campo, Antonio
  • Ruiz-Partida, Rafael
  • Hernández-Sierra, María del Pilar
  • Villamayor-Belinchón, Laura
  • Bravo, Jerónimo
  • Llácer, José Luis
  • Marina, Alberto
  • Rubio, Vicente
  • San-Félix, Ana
  • Geller, Ron
  • Peréz-Pérez, María-Jesús
26 páginas, 6 figuras, 2 tablas., Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, by infecting cells via the interaction of its spike protein (S) with the primary cell receptor angiotensin-converting enzyme (ACE2). To search for inhibitors of this key step in viral infection, we screened an in-house library of multivalent tryptophan derivatives. Using VSV-S pseudoparticles, we identified compound 2 as a potent entry inhibitor lacking cellular toxicity. Chemical optimization of 2 rendered compounds 63 and 65, which also potently inhibited genuine SARS-CoV-2 cell entry. Thermofluor and microscale thermophoresis studies revealed their binding to S and to its isolated receptor binding domain (RBD), interfering with the interaction with ACE2. High-resolution cryoelectron microscopy structure of S, free or bound to 2, shed light on cell entry inhibition mechanisms by these compounds. Overall, this work identifies and characterizes a new class of SARS-CoV-2 entry inhibitors with clear potential for preventing and/or fighting COVID-19., Funding for this project was provided by grants from the European Commission NextGenerationEU fund (EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global), Crue-CSIC-Santander Fondo Supera Covid-19, and CSIC grant (CSIC-COV19-082) to R.G., M.-J-P.-P., V.R., J.B., A.M., and J.-L.L. and CIBERER, Instituto de Salud Carlos III (COV20/00437) to V.R., J.B., A.M., and J.-L.L. In addition, this work was funded by grant (Covid_19-SCI) from the Generalitat Valenciana y Conselleria de Innovación, Universidades, Ciencia y Sociedad digital to R.G., and by grants PID2020-120322RB-C21 and PID2020-116880GB-I00 from the Agencia Estatal de Investigación of the Spanish Government to V.R. and J.-L.L., respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular and Serological Studies on Potential SARS-CoV-2 Infection among 43 Lemurs under Human Care—Evidence for Past Infection in at Least One Individual

  • Musoles-Cuenca, Beatriz
  • Aguiló-Gisbert, Jordi
  • Lorenzo, Teresa
  • Canales, Rocío
  • Ballester, Beatriz
  • Romani-Cremaschi, Umberto
  • Martínez-Valverde, Rosa
  • Maiques, Elisa
  • Marteles, Diana
  • Rueda, Pablo
  • Rubio, Vicente
  • Villanueva-Saz, Sergio
  • Rubio-Guerri, Consuelo
In the setting of the recent COVID-19 pandemic, transmission of SARS-CoV-2 to animals has been reported in both domestic and wild animals and is a matter of concern. Given the genetic and functional similarities to humans, non-human primates merit particular attention. In the case of lemurs, generally considered endangered, they are believed to be susceptible to SARS-CoV-2 infection. We have conducted a study for evidence of SARS-CoV-2 infection among the 43 lemurs of Mundomar, a zoological park in Benidorm, Spain. They belong to two endangered lemur species, 23 black-and-white ruffed lemurs (Varecia variegata) and 20 ring-tailed lemurs (Lemur catta). Health assessments conducted in 2022 and 2023 included molecular analyses for SARS-CoV-2 RNA of oral and rectal swabs using two different RT-qPCR assays, always with negative results for SARS-CoV-2 in all animals. The assessment also included serological testing for antibodies against the receptor-binding domain (RBD) of the spike protein (S) of SARS-CoV-2, which again yielded negative results in all animals except one black-and-white ruffed lemur, supporting prior infection of that animal with SARS-CoV-2. Our data, while not indicating a high susceptibility of lemurs to SARS-CoV-2 infection, show that they can be infected, adding to the existing information body on potential ways for SARS-CoV-2 virus spreading in zoos, highlighting the need for animal surveillance for the virus., This research received external funding to VR, CRG, and EM from the Spanish Agencia Estatal de Investigación (Plan Estatal de I+D+i) (PID2020-120322RB-C21)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity

  • Revuelta, Julia
  • Rusu, Luciana
  • Francés-Gómez, Clara
  • Trapero, Elena
  • Iglesias, Susana
  • Pinilla, Eva Calvo
  • Blázquez, Ana-Belén
  • Gutiérrez-Adán, Alfonso
  • Konuparamban, Acsah
  • Moreno, Oscar
  • Gómez Martínez, María
  • Forcada-Nadal, Alicia
  • López-Redondo, Marisa
  • Avilés-Alía, Ana Isabel
  • Llácer, José Luis
  • Llop, Jordi
  • Martín-Acebes, M. A.
  • Geller, Ron
  • Fernández-Mayoralas, Alfonso
Enveloped viruses enter cells by binding to receptors present on host cell membranes, which trigger internalization and membrane fusion. For many viruses, this either directly or indirectly involves interaction with membrane-anchored carbohydrates, such as heparan sulfate, providing a potential target for a broad-spectrum antiviral approach. Based on this hypothesis, we screened a library of functionalized chitosan sulfates that mimic heparan sulfate in cellular membranes for inhibition of SARS-CoV-2 and respiratory syncytial virus (RSV) entry. An array of compounds blocking SARS-CoV-2 and RSV were identified, with the lead compound displaying broad-spectrum activity against multiple viral strains and clinical isolates. Mechanism of action studies showed the drug to block viral entry irreversibly, likely via a virucidal mechanism. Importantly, the drug was non-toxic in vivo and showed potent post-exposure therapeutic activity against both SARS-CoV-2 and RSV. Together, these results highlight the potential of functionalized carbohydrates as broad-spectrum antivirals targeting respiratory viruses., This work acknowledges the use of ICTS-ReDIB, supported by the Ministry of Science, Innovation and Universities (MICIU) at biomaGUNE. We thank Raquel Palao (ICTP-CSIC) for the GPC analysis. Funding for this project was provided by grants SGL2021-03-009, SGL2103053, and SGL2021-03-052 from European Union NextGenerationEU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094, to RG, to MAM-A, J. R., A. F.-M., J.L.L, and the IBV-Covid19-Pipeline acknowledge the financial support provided by CSIC (grants CSIC-COV19-013, CSIC-COV19-082) and the MICIN (grants PID2019-105337RB-C21, PID2020-120322RB-C21, PID2020-116880GB-I00). RG also acknowledges funding from the Generalitat Valenciana (GVA, GVCOVID19-2020-05). MAM-A acknowledges funding from the European Union’s Horizon Europe research and innovation program under grant agreement number 101137506 (NAVIPP)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Four Novel SARS-CoV-2 Infected Feral American Mink (Neovison Vison) Among 60 Individuals Caught in the Wild

  • Suita, Francesca
  • Padilla-Blanco, Miguel
  • Aguiló-Gisbert, Jordi
  • Lorenzo-Bermejo, Teresa
  • Ballester, Beatriz
  • Cardells, Jesús
  • Maiques, Elisa
  • Rubio, Vicente
  • Lizana, Víctor
  • Rubio-Guerri, Consuelo
This article belongs to the Section Wildlife., The data generated and analyzed during this study have been deposited in GenBank. The accession numbers for the sequences are S gene region: PQ461249; N gene region mutation C28932T: PQ461250; N gene region mutation GGG28881-28883AAC: PQ519871; ORF10 gene region: PQ461251. Additional data supporting the findings of this study are available from the corresponding authors upon reasonable request., [Simple Summary] The COVID-19 pandemic, caused by the SARS-CoV-2 virus, raised awareness of the role animals can play in the spread of infectious diseases. Mink are highly susceptible to this virus and can transmit it to other mink and humans. In this study, we tested 60 wild-living (feral) American mink captured in eastern Spain to detect possible SARS-CoV-2 infections. We found four positive animals. Combined with a previous pilot study that detected 2 infected mink among 13, only 6 out of 73 animals tested positive. This finding indicates that while infection can occur in the wild, the overall prevalence remains low. We also analyzed the body condition and reproductive status of the mink, which showed seasonal breeding and high population turnover, consistent with other wild mink populations. These results suggest limited spread of SARS-CoV-2 in feral mink and highlight the importance of continued monitoring of wildlife to detect emerging diseases that may affect both animals and humans., [Abstract] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the zoonotic virus responsible for the COVID-19 pandemic, has caused global health and economic disruption. American mink (Neovison vison) are highly susceptible to SARS-CoV-2 and capable of transmitting it to both mink and humans. We previously reported the first detection of SARS-CoV-2 in feral mink, with two positive cases among 13 animals in the upper courses of two rivers in the Valencian Community, eastern Spain. Here, we expand that study with 60 additional feral mink sampled from November 2020 to May 2022. Four new positives were identified by two-step RT-PCR assay on necropsy samples, including nasal and rectal swabs, lung tissue, lymph nodes, and fetuses from three pregnant females. In total, six of 73 mink tested positive, all with low viral loads. Sanger sequencing confirmed infection and revealed clustering with the B.1.177 and Alpha variants. Body weight and reproductive status analyses indicated seasonal breeding and high population turnover, consistent with other wild mink populations. Our findings reveal that SARS-CoV-2 circulation is limited in feral mink, at least in this region. They underscore the key importance of wildlife surveillance as an element of the One Health strategy, which encompasses humans, animals, and the environment., This research received external funding for V.R., C.R.G., and E.M. from the Spanish Agencia Estatal de Investigación-MICIN (Plan Estatal de I+D+i) (PID2020-120322RB-C21)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Exploring SARS-CoV-2 spike RBD pockets as targets for generic drugs: a combined computational, biophysical, and biological approach

  • García-Marín, Javier
  • Francés-Gómez, Clara
  • Forcada-Nadal, Alicia
  • Adhav, Anmol
  • Marco-Marín, Clara
  • Rubio, Vicente
  • Marina, Alberto
  • Llácer, José Luis
  • Geller, Ron
  • Martín-Santamaría, Sonsoles
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was a pandemic that killed over 6 million people worldwide, with devastating social and economic impacts still being felt today. Despite the recent and successful development of RNA vaccines, there remains a need for antiviral drugs to treat patients at risk for drug resistance, immunological disorders, or reduced treatment efficacy. In this regard, several computational approaches have been carried out to find small molecules targeting the SARS-CoV-2 Spike S protein, and drug repurposing strategies have been applied to find rapid and accessible candidates for clinical use. In this work, we conduct an exhaustive computational study of the receptor binding domain (RBD) of the spike S protein to identify and characterize druggable pockets and to identify generic drugs as blockers of SARS-CoV-2 entry. The combination of computational screening, biophysical studies in both the RBD (Wuhan-Hu-1 and Omicron BA.1 variants) and Spike protein (Wuhan variant), and the in vitro assays in SARS-CoV-2 Wuhan-Hu-1, Delta, and Omicron BA.1 has led to the identification of generic drugs with S protein binding properties and antiviral activity. Based on in vitro antiviral activity and mechanism of action analysis at the atomic/molecular level, fingolimod exhibited the most promising profile for a possible SARS-CoV-2 antiviral treatment., Funding for this project was provided by grants from the European Commission NextGenerationEU fund (EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global), Crue-CSIC-Santander Fondo Supera Covid-19 “BlockAce”, and CSIC Grant (CSIC-COV19-082) to S.M.-S., R.G., V.R., A.M., and J.-L.L. J.G.-M. and S.M.-S. gratefully acknowledge BioSolveIT for providing a one-year SeeSAR license during the Scientific Challenge Summer 2020. Grants PID2020-113588RB-I00 and PID2023-152271NB-I00 to S.M.-S. and PID2020-120322RB-C21 to V.R., funded by the Spanish Ministry for Science and Innovation, are also gratefully acknowledged, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A tetrapodal tryptophan derivative with multiple exposed free carboxylic acids blocks host cell entry of omicron SARS-Cov-2 and respiratory syncytial virus

  • Martí-Marí, Olaia
  • Moreno-Simoni, Marta
  • Avilés-Alía, Ana Isabel
  • Rusu, Luciana
  • Forcada-Nadal, Alicia
  • Adhav, Anmol
  • López-Redondo, Marisa
  • Blázquez, Ana-Belén
  • Esteban, Ana
  • Jiménez de Oya, Nereida
  • Marina, Alberto
  • Rubio, Vicente
  • Llácer, José Luis
  • Gago, Federico
  • Martín-Acebes, M. A.
  • Peréz-Pérez, María-Jesús
  • Geller, Ron
  • San-Félix, Ana
Omicron sublineages of SARS-CoV-2 have accelerated the spread of the virus and facilitated immune escape. In this work, we demonstrate that compound 2, a potent HIV and enterovirus A71 (EV-A71) entry inhibitor previously discovered in our research group, also displays potent in vitro activity against different SARS-CoV-2 Omicron variants while showing no activity against the ancestral SARS-CoV-2 Wuhan strain. Moreover, its sodium salt (2-Na salt) exhibited in vivo antiviral activity in a murine model of Omicron BA.1. infection. Indeed, biophysical and cryo-EM studies revealed binding of 2-Na salt to the Omicron BA.1 spike (S) protein stabilizing a "closed" form in which ∼75% of the S particles have all RBDs down, unlike the usual "open" form with one RBD up. Such "closed" form decreases S avidity for the cellular receptor ACE2, thus inhibiting viral entry. Computer-assisted modeling studies strongly suggest that 2 can interact with the intersubunit cavity of the S trimer of the Omicron BA.1 subvariant, making use of the multivalency principle. In this context, compound 2 can be considered a pharmacological tool for studying and validating new antiviral strategies against Omicron variants. We also identified 2 as a potent inhibitor of RSV and the Ebola virus. The effectiveness of 2 against a diverse set of viruses of different families supports its use as a promising lead for the development of entry inhibitors against current and future viral infections, representing a meaningful advance in the field., Funding for this project was provided by grants SGL2021-03-009, SGL2103053, and SGL2021-03-052 from European Union Next Generation EU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094. The work was also supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033/FEDER, UE under projects PID2022-137372OR-C22 (M.-J.P.-P.), PID2022-136307OB-C21 (A.S.-F.), and PID2022-136307OB-C22 (F.G.) together with CSIC Intramural projects PIE202380E090 (M.-J.P.-P. and A.S.-F.) and PIE 202340E181 (M.A.M.-A.). V.R. and J.L.L. acknowledge the financial support provided by MICIN (grants PID2020-120322RB-C21 and PID2020-116880GB-I00, respectively)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Molecular and Serological Studies on Potential SARS-CoV-2 Infection among 43 Lemurs under Human Care—Evidence for Past Infection in at Least One Individual

  • Musoles-Cuenca, Beatriz
  • Aguiló-Gisbert, Jordi
  • Lorenzo-Bermejo, Teresa
  • Canales, Rocío
  • Ballester, Beatriz
  • Romani-Cremaschi, Umberto
  • Martínez-Valverde, Rosa
  • Maiques, Elisa
  • Marteles, Diana
  • Rueda, Pablo
  • Rubio, Vicente
  • Villanueva-Saz, Sergio
  • Rubio-Guerri, Consuelo
In the setting of the recent COVID-19 pandemic, transmission of SARS-CoV-2 to animals has been reported in both domestic and wild animals and is a matter of concern. Given the genetic and functional similarities to humans, non-human primates merit particular attention. In the case of lemurs, generally considered endangered, they are believed to be susceptible to SARS-CoV-2 infection. We have conducted a study for evidence of SARS-CoV-2 infection among the 43 lemurs of Mundomar, a zoological park in Benidorm, Spain. They belong to two endangered lemur species, 23 black-and-white ruffed lemurs (Varecia variegata) and 20 ring-tailed lemurs (Lemur catta). Health assessments conducted in 2022 and 2023 included molecular analyses for SARS-CoV-2 RNA of oral and rectal swabs using two different RT-qPCR assays, always with negative results for SARS-CoV-2 in all animals. The assessment also included serological testing for antibodies against the receptor-binding domain (RBD) of the spike protein (S) of SARS-CoV-2, which again yielded negative results in all animals except one black-and-white ruffed lemur, supporting prior infection of that animal with SARS-CoV-2. Our data, while not indicating a high susceptibility of lemurs to SARS-CoV-2 infection, show that they can be infected, adding to the existing information body on potential ways for SARS-CoV-2 virus spreading in zoos, highlighting the need for animal surveillance for the virus.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Finding of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) in a Wild Eurasian River Otter (Lutra lutra) Highlights the Need for Viral Surveillance in Wild Mustelids

  • Padilla-Blanco, Miguel
  • Aguiló-Gisbert, Jordi|||0000-0002-2162-9495
  • Rubio, Vicente
  • Lizana, Victor|||0000-0003-2490-6336
  • Chillida-Martínez, Eva
  • Cardells-Peris, Jesús|||0000-0003-1401-772X
  • Maiques, Elisa
  • Rubio-Guerri, Consuelo
Animals have been involved in the three known outbreaks of severe respiratory syndromes due to coronaviruses (years 2005, 2012, and 2019). The pandemic nature of the SARS-CoV-2 outbreak increases the likelihood of infection from humans of susceptible animal species that, thus, could become secondary viral hosts and even disease reservoirs. We present evidence of spillover infection of wild mustelids by reporting the presence of SARS-CoV-2 in a Eurasian river otter found near a water reservoir in the Valencian Community (Spain). We detected the virus using two different commercial RTqPCR assays on RNA extracted from the nasopharynx (swabbing) and from lung tissue and mediastinal lymph node homogenates. The corresponding samples from two additional otters from distant sites tested negative in identical assays. The diagnosis in the positive otter was confirmed by two-tube RT-PCR assay in which RNA was first retrotranscribed, and then specific regions of the spike (S), nucleocapsid (N), and ORF10 genes were separately amplified from the produced cDNA, followed by electrophoretic visualization and Sanger sequencing. The sequences of the amplified products revealed some non-synonymous changes in the N and ORF10 partial sequences, relative to the consensus sequence. These changes, identified already in human patient samples, point to human origin of the virus, although their specific combination was unique. These findings, together with our previous report of SARS-CoV-2 infection of feral American mink, highlight the need for SARS-CoV-2 surveillance of wild or feral mustelids to evaluate the risk that these animals could become SARS-CoV-2 reservoirs.